https://hyxtide.com/new-glp-1-analog-catalog-line-50-ready-to-ship-skus/2026-10-29T21:51:43+08:00https://hyxtide.com/phase-iii-manufacturing-suite-now-operational-60-capacity-increase/2026-10-29T21:51:43+08:00https://hyxtide.com/multi-year-supply-agreement-signed-with-top-5-european-pharma/2026-10-29T21:51:43+08:00https://hyxtide.com/ich-q7-third-party-audit-completed-zero-critical-findings/2026-10-29T21:51:43+08:00https://hyxtide.com/glp-1-peptide-market-to-reach-100b-by-2030-what-it-means-for-manufacturers/2026-10-29T21:51:43+08:00https://hyxtide.com/hyxtide-scientists-publish-on-novel-continuous-flow-synthesis-platform/2026-10-29T21:51:43+08:00https://hyxtide.com/cosmetic-peptide-line-expanded-15-new-anti-aging-skin-care-apis/2026-10-29T21:02:12+08:00https://hyxtide.com/hyxtide-ranked-3-in-global-peptide-cro-cmo-survey-2025/2026-10-29T21:51:43+08:00https://hyxtide.com/fda-guidance-update-on-peptide-api-manufacturing-key-takeaways/2026-10-29T21:51:43+08:00https://hyxtide.com/distribution-partnership-established-in-japan-and-south-korea/2026-10-29T21:51:43+08:00https://hyxtide.com/collaboration-with-mit-on-next-generation-peptide-drug-delivery-systems/2026-10-29T21:02:12+08:00https://hyxtide.com/eu-gmp-certificate-renewed-scope-extended-to-include-fill-finish-operations/2026-10-29T21:51:43+08:00